| |
| |
|
| Insider
Information: |
Broadfin Healthcare Master Fund Ltd |
| Relationship: |
Director |
| City: |
Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
12,873,344 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$56,897,288 |
|
|
| Total
Shares |
12,873,344 |
|
|
| Total
Value |
$56,897,288 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
0.0
|
| Percentage
Gain/Loss : |
 36.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
10% Owner |
|
0 |
2016-11-29 |
9,742,771 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Director |
2019-01-31 |
0 |
2019-01-31 |
3,130,573 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2019-08-13 |
0 |
2022-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2022-03-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,588,395) |
0 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2022-02-11 |
4 |
OE |
$1.80 |
$4,360,000 |
I/I |
2,422,222 |
7,588,395 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
7,684 |
5,166,173 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-11-12 |
4 |
B |
$3.20 |
$320,000 |
I/I |
100,000 |
5,058,489 |
2.1 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-11-05 |
4 |
B |
$3.47 |
$894,566 |
I/I |
257,800 |
4,958,489 |
2.1 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-08-10 |
4 |
OE |
$2.93 |
$43,950 |
I/I |
15,000 |
4,700,689 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-08-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
30,000 |
4,685,689 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-05-13 |
4 |
B |
$3.25 |
$162,500 |
I/I |
50,000 |
4,655,689 |
2.1 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-05-12 |
4 |
B |
$3.24 |
$324,000 |
I/I |
100,000 |
4,605,689 |
2.1 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2021-05-11 |
4 |
B |
$3.16 |
$474,000 |
I/I |
150,000 |
4,505,689 |
2.1 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2020-08-07 |
4 |
OE |
$0.00 |
$43,950 |
I/I |
45,000 |
4,355,689 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2019-08-13 |
4 |
OE |
$0.00 |
$0 |
I/I |
18,123 |
4,300,066 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2019-01-31 |
4 |
A |
$0.00 |
$0 |
I/I |
27,900 |
3,130,573 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2016-11-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,472,940 |
9,742,771 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
|
– – – |
2016-11-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,269,831 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
